QIAGEN NV (QGEN)
41.37
+0.36
(+0.88%)
USD |
NYSE |
Apr 10, 10:39
QIAGEN Price : 41.37 for April 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InflaRx NV | 1.04 |
| CDT Equity, Inc. | 5.05 |
| LENZ Therapeutics, Inc. | 9.21 |
| Liminatus Pharma, Inc. | 0.1882 |
| Oruka Therapeutics, Inc. | 61.00 |
Price Related Metrics
| PE Ratio | 20.11 |
| PS Ratio | 4.090 |
| PEG Ratio | 0.0480 |
| Price to Book Value | 2.241 |
| Price to Free Cash Flow | 19.11 |
| Earnings Yield | 4.97% |
| Market Cap | 8.522B |
| PEGY Ratio | 0.0480 |
| Operating PE Ratio | 16.39 |
| Normalized PE Ratio | 18.47 |